Curative Biotechnology Stock Market Value
| CUBT Stock | USD 0.01 0.0001 1.15% |
| Symbol | Curative |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Curative Biotechnology. If investors know Curative will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Curative Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Curative Biotechnology is measured differently than its book value, which is the value of Curative that is recorded on the company's balance sheet. Investors also form their own opinion of Curative Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Curative Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Curative Biotechnology's market value can be influenced by many factors that don't directly affect Curative Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Curative Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Curative Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Curative Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Curative Biotechnology 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Curative Biotechnology's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Curative Biotechnology.
| 06/09/2023 |
| 11/30/2024 |
If you would invest 0.00 in Curative Biotechnology on June 9, 2023 and sell it all today you would earn a total of 0.00 from holding Curative Biotechnology or generate 0.0% return on investment in Curative Biotechnology over 540 days. Curative Biotechnology is related to or competes with Covalon Technologies, Mosaic Immunoengineerin, and Cellectis. Curative Biotechnology, Inc. operates as a development-stage biomedical company More
Curative Biotechnology Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Curative Biotechnology's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Curative Biotechnology upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 15.55 | |||
| Information Ratio | 0.0151 | |||
| Maximum Drawdown | 79.53 | |||
| Value At Risk | (20.45) | |||
| Potential Upside | 25.0 |
Curative Biotechnology Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Curative Biotechnology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Curative Biotechnology's standard deviation. In reality, there are many statistical measures that can use Curative Biotechnology historical prices to predict the future Curative Biotechnology's volatility.| Risk Adjusted Performance | 0.0284 | |||
| Jensen Alpha | 0.3649 | |||
| Total Risk Alpha | (2.05) | |||
| Sortino Ratio | 0.0139 | |||
| Treynor Ratio | (2.13) |
Curative Biotechnology Backtested Returns
Curative Biotechnology appears to be out of control, given 3 months investment horizon. Curative Biotechnology secures Sharpe Ratio (or Efficiency) of 0.0247, which signifies that the company had a 0.0247% return per unit of risk over the last 3 months. We have found thirty technical indicators for Curative Biotechnology, which you can use to evaluate the volatility of the firm. Please makes use of Curative Biotechnology's Downside Deviation of 15.55, risk adjusted performance of 0.0284, and Mean Deviation of 9.25 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Curative Biotechnology holds a performance score of 1. The firm shows a Beta (market volatility) of -0.16, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Curative Biotechnology are expected to decrease at a much lower rate. During the bear market, Curative Biotechnology is likely to outperform the market. Please check Curative Biotechnology's maximum drawdown and the relationship between the expected short fall and period momentum indicator , to make a quick decision on whether Curative Biotechnology's price patterns will revert.
Auto-correlation | -0.35 |
Poor reverse predictability
Curative Biotechnology has poor reverse predictability. Overlapping area represents the amount of predictability between Curative Biotechnology time series from 9th of June 2023 to 5th of March 2024 and 5th of March 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Curative Biotechnology price movement. The serial correlation of -0.35 indicates that nearly 35.0% of current Curative Biotechnology price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.35 | |
| Spearman Rank Test | -0.34 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Curative Biotechnology lagged returns against current returns
Autocorrelation, which is Curative Biotechnology stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Curative Biotechnology's stock expected returns. We can calculate the autocorrelation of Curative Biotechnology returns to help us make a trade decision. For example, suppose you find that Curative Biotechnology has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Curative Biotechnology regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Curative Biotechnology stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Curative Biotechnology stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Curative Biotechnology stock over time.
Current vs Lagged Prices |
| Timeline |
Curative Biotechnology Lagged Returns
When evaluating Curative Biotechnology's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Curative Biotechnology stock have on its future price. Curative Biotechnology autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Curative Biotechnology autocorrelation shows the relationship between Curative Biotechnology stock current value and its past values and can show if there is a momentum factor associated with investing in Curative Biotechnology.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Curative Stock Analysis
When running Curative Biotechnology's price analysis, check to measure Curative Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curative Biotechnology is operating at the current time. Most of Curative Biotechnology's value examination focuses on studying past and present price action to predict the probability of Curative Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curative Biotechnology's price. Additionally, you may evaluate how the addition of Curative Biotechnology to your portfolios can decrease your overall portfolio volatility.